Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 698

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 698
---
     390  
     453 

    F-23

MY
SIZE, INC. AND ITS SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

U.S.
dollars in thousands (except share data and per share data)

NOTE
14 - STOCK BASED COMPENSATION (Cont.)

Options
issued to consultants

    a.
    In
    March 2023, the Company entered into a two-year agreement with a consultant to provide services to the Company including assisting
    the Company to promote, market and sell the Company’s technology to potential customers. Pursuant to such agreement and in
    partial consideration for such consulting services, the Company agreed to issue to the consultant options to purchase up to 500 shares
    of the Company’s common stock upon execution of the agreement. The options are exercisable at $24.00
    per share and shall vest in two equal instalments every twelve months starting March 2023. Unexercised options shall expire 3 years
    from the effective date.

    b.
    In
                                            July 2023, the Company entered into a six month agreement with a consultant to provide services to the Company, including
                                            assisting the Company to promote, market and sell the Company’s technology to potential
                                            customers and make strategic introductions and inquiries with interested parties in the financial
                                            community. Pursuant to the agreement and in partial consideration for such consulting
                                            services, the Company issued to the consultant (i) 5,000 shares of restricted common stock
                                            of the Company, (ii) a warrant to purchase 12,500 shares of common stock at an exercise price
                                            of $4.00 per share and exercisable for a term of 36 months from the date of issuance, and
                                            (iii) a warrant to purchase 12,500 shares of common stock at an exercise price of $6.00 per
                                            share and exercisable for a term of 36 months from the date of issuance.
     
    The
    issuance was approved by the Company’s board of directors in February 2024.
     
    In
    the year ended December 31, 2024, the Company recorded $71, as stock-based equity awards with respect to the consultant. No expenses
    were recorded in the fiscal year ended December 31, 2023 with respect to the consultant.

    F-24

MY
SIZE, INC. AND ITS